PEDBASE.org - The Pediatric Database -
Detailed information of VON HIPPEL-LINDAU DISEASE
VON HIPPEL-LINDAU DISEASE
DEFINITION:
A neurocutaneous syndrome characterized by hemangioblastomas (cerebellar
and retinal), visceral cysts, and tumors.
EPIDEMIOLOGY:
- incidence: 1/36,000
- age of onset:
- any but usually in the 2nd decade
- risk factors:
- familial - autosomal dominant
- chrom.#: 3p25-p26
- gene: plasma membrane calcium-transporting ATPase isoform
2 (PMCA-2) gene
- penetrance is almost complete by age 65 with delayed and
variable expression even within the same kindred
PATHOGENESIS:
- genetic defect -> mutation of PMCA-2 gene -> familial cancer
syndrome that predisposes affected individuals to a variety of
tumors:
- hemangioblastomas of the central nervous system (CNS) and
retina
- renal cell carcinomas
- pheochromocytomas
- the PMCA-2 gene has been identified as a candidate for the
VHL gene (Yao, M., Human Genetics 92:605-614 [1993])
- congenital capillary hemangioblastomas are the basic lesion
of VHL and involve the cerebellum and retina
PATHOLOGY:
- tumors are usually well circumscribed and may be solid or
cystic
- microscopically, present as large numbers of thin-walled,
closely packed blood vessels
- usually found in the paramedial aspect and associated with
prominent vessels but any cerebellar region affected
2. Retinal Hemangioblastoma (or angiomata)
- characterized by small, raised masses of retinal tissue
composed of thin-walled capillaries that are fed by large and
tortuous arterioles and venules
- may be divided into 3 categories
- by ophthalmoscopic examination, may appear as a dilated
artery leading from the disk to a peripheral tumor with an
engorged vein
- usually observed in the retinal periphery (so vision
unaffected)
DIAGNOSTIC CRITERIA:
1. more than 1 hemangioblastoma in the CNS
2. 1 hemangioblastoma in the CNS + visceral cyst or renal
carcinoma
3. any manifestation with a family history
CLINICAL FEATURES:
1. Neurological Manifestations
1. CNS Hemangioblastomas
- make up 2% of all brain tumors
- make up 7-10% of all posterior fossae tumors
2. Cerebellar Hemangioblastomas (83%)
- mean age of onset is 32 yrs; before age 15 is rare
- may present with posterior fossae signs/symptoms
- obstructive hydrocephalus (with elevated intracranial
pressure)
- cerebellar signs (ataxia, nystagmus)
- coning
- associated with polycythemia in 10-50% of patients
- all children presenting with cerebellar hemangioblastomas
have VHL
3. Other Sites
1. Spinal Cord
- 2nd most frequent site of CNS hemangioblastomas
- present with abnormalities of proprioception, gait, and
bladder dysfunction
2. Others
- Cerebral Hemispheres (20%), pituitary, medulla
2. Ophthalmologic Manifestations
1. Retinal Hemangioblastomas (46%)
- may appear as early as the 1st decade but usually in 2nd
(before the presentation of cerebellar hemangioblastomas)
- may present:
- vision unaffected (if tumor in periphery)
- visual impairment with:
- macular involvement
- intraocular hemorrhage
- retinal detachment secondary to exudation
- may be multiple and bilateral
- no sex predilection
3. Others
1. Visceral Cysts
- tend to progress and become apparent during adult life
- pancreatic (72%)
- renal (59%)
- hepatic (17%)
- epididymis (7%)
2. Other Tumors
1. Pheochromocytomas (17%)
- usually bilateral
- limited to certain families where a pheochromocytoma is
the first expression of VHL (may become manifest as early as
5 years of age)
- may lead to subarachnoid hemorrhage in presence of a
- CNS hemangioblastoma
2. Renal Cell Carcinoma (51%)
- malignant and most common cause of death in VHL
3. Neurofibromatoses
4. Multiple Endocrine Neoplasia Syndrome
Note: the clinical features vary widely from benign to
devastating
INVESTIGATIONS:
1. Imaging Studies
1. CT/MRI
- cerebellar hemangioblastomas appear as cystic lesions with
a vascular mural nodule
- for visceral cysts and tumors
2. Arteriography
- to visualize blood supply to hemangioblastomas
2. Serum
- polycythemia (in 50% of patients with cerebellar
hemangioblastomas)
- hypercalcemia (with pheochromocytomas)
3. CSF
- elevated CSF protein with cerebellar hemangioblastomas
4. Urine
- VMA and HVA if suspect a pheochromocytoma
MANAGEMENT:
1. Surgery
1. CNS Hemangioblastomas
- total surgical removal is curative with evaculation of
cystic structures and removal of mural nodules
- recurrence is common with partial tumor resection
2. Retinal Hemangioblastomas
- laser therapy - photocoagulation and cryocoagulation
2. Preventative
- for children at risk, screen for:
- retinal hemangioblastomas q5y
- CNS hemangioblastomas q5y after age 15
INTERNET LINKS:
Von
Hippel-Lindau Disease Family Alliance
|
Pediatric Database - VON HIPPEL-LINDAU DISEASE
Pediatric Organization - Pedbase [at] Gmail.com